Home/Pipeline/Allogeneic Cell‑in‑a‑Box® for GvHD

Allogeneic Cell‑in‑a‑Box® for GvHD

Graft‑versus‑host disease

Phase 1Active

Key Facts

Indication
Graft‑versus‑host disease
Phase
Phase 1
Status
Active
Company

About Austrianova Biotechnology

Austrianova delivers a patented cell‑encapsulation platform for immune‑protected, off‑the‑shelf cell and probiotic therapies.

View full company profile